Keyword | CPC | PCC | Volume | Score | Length of keyword |
---|---|---|---|---|---|
fda guidance bispecific antibody development | 0.75 | 1 | 5812 | 92 | 44 |
fda | 0.43 | 0.7 | 1625 | 44 | 3 |
guidance | 0.42 | 0.8 | 9721 | 86 | 8 |
bispecific | 0.51 | 1 | 4729 | 13 | 10 |
antibody | 0.73 | 1 | 4492 | 24 | 8 |
development | 0.82 | 0.9 | 4425 | 30 | 11 |
Keyword | CPC | PCC | Volume | Score |
---|---|---|---|---|
fda guidance bispecific antibody development | 1.26 | 0.9 | 7446 | 26 |
bispecific antibody development programs fda | 1.86 | 0.2 | 7599 | 57 |
fda approved bispecific antibody | 1.46 | 0.2 | 7340 | 70 |
fda approved bispecific antibody drugs | 0.81 | 0.9 | 1751 | 80 |
bispecific antibody fda approval | 1.29 | 0.9 | 1346 | 66 |
bispecific antibodies approved by fda | 0.64 | 0.6 | 6999 | 50 |
bispecific antibody development programs | 0.05 | 0.9 | 9387 | 13 |
development of bispecific antibodies | 1.7 | 0.5 | 9404 | 8 |
bispecific monoclonal antibody development | 0.12 | 0.3 | 9928 | 38 |
bispecific antibody cell line development | 1.84 | 0.1 | 2419 | 16 |
list of approved bispecific antibodies | 1.24 | 0.6 | 1118 | 69 |
bispecific antibodies in clinical trials | 1.97 | 0.1 | 1370 | 61 |
anti drug antibody fda guidance | 1.59 | 0.3 | 3398 | 84 |
bispecific antibodies and their applications | 0.59 | 0.1 | 9195 | 26 |
bispecific antibody format review | 0.72 | 0.9 | 4182 | 61 |
bispecific antibodies in oncology | 0.83 | 0.3 | 4013 | 57 |
bispecific monoclonal antibody design | 0.11 | 0.7 | 2093 | 33 |
list of bispecific antibodies | 0.48 | 0.3 | 408 | 11 |
the making of bispecific antibodies | 1.25 | 0.2 | 6665 | 36 |